Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

Kayci Huff-Hardy; Mai Bedair; Rebecca Vazquez; Ezra Burstein

doi:10.1097/MIB.0000000000001232

Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

Kayci Huff-Hardy, Mai Bedair, Rebecca Vazquez, Ezra Burstein

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E49
Journal	Inflammatory bowel diseases
Volume	23
Issue number	10
DOIs	https://doi.org/10.1097/MIB.0000000000001232
State	Published - Oct 1 2017

ASJC Scopus subject areas

Immunology and Allergy
Gastroenterology

Access to Document

10.1097/MIB.0000000000001232

Cite this

@article{4dc67217cae34a56a23471bd3cf911c4,

title = "Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease",

author = "Kayci Huff-Hardy and Mai Bedair and Rebecca Vazquez and Ezra Burstein",

year = "2017",

month = oct,

day = "1",

doi = "10.1097/MIB.0000000000001232",

language = "English (US)",

volume = "23",

pages = "E49",

journal = "Inflammatory bowel diseases",

issn = "1078-0998",

publisher = "John Wiley and Sons Inc.",

number = "10",

}

TY - JOUR

T1 - Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

AU - Huff-Hardy, Kayci

AU - Bedair, Mai

AU - Vazquez, Rebecca

AU - Burstein, Ezra

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85029750172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029750172&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000001232

DO - 10.1097/MIB.0000000000001232

M3 - Letter

C2 - 28858074

AN - SCOPUS:85029750172

SN - 1078-0998

VL - 23

SP - E49

JO - Inflammatory bowel diseases

JF - Inflammatory bowel diseases

IS - 10

ER -

Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this